Herbalife trades at an extreme discount — forward price-to-earnings below 4x and a PEG of 0.23 — backed by exceptional free cash flow conversion at 146% of net income and a recent return to earnings beats, though concentrated product and customer exposure and substantial options-market skepticism limit the setup to a modest initial position.
Thesis pillars
- Product Customer Concentration Vulnerability↑Improving
- Exceptional Free Cash Flow Quality→Stable
- Extreme Valuation Discount↓Deteriorating
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 18, 2026· older than 90 days
Herbalife Ltd. (HLF) Stock Analysis
Inst Constrain edge
Consumer Defensive · Packaged Foods
Sell if holding. At $14.38, A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: Weight Management (54.5%); Concentration risk — Customer: independent Members.
Herbalife sells nutrition and wellness products — weight management (54.5% of 2025 net sales), targeted nutrition, sports, and outer nutrition — through a direct-selling network of approximately 6.4 million Members across 95 markets. Revenue is earned when Members purchase at... Read more
Sell if holding. At $14.38, A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: Weight Management (54.5%); Concentration risk — Customer: independent Members. Chart setup: No clear chart pattern; technical signals are mixed. Score 6.4/10, moderate confidence.
Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news boost earnings 0.70, earnings proximity 105d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated Oct 31, 2026Recent Developments — Herbalife Ltd.
Latest news
- NEWS Herbalife (NYSE:HLF) Stock Dropped to Hold by Zacks Research - MarketBeat — MarketBeat Oct 31, 2026 negative
- NEWS What Herbalife Doubters Got Wrong - Simply Wall St — Simply Wall St Oct 27, 2026 positive
- NEWS Earnings Flash (HLF) Herbalife Ltd. Posts Q2 Adjusted EPS $0.51 per Share, vs. FactSet Est of $0.54 - marketscreener.com — marketscreener.com Aug 5, 2026 negative
- NEWS Herbalife (NYSE:HLF) Beats Q2 CY2026 Sales Expectations - StockStory — StockStory Aug 5, 2026 positive
- NEWS Herbalife (NYSE:HLF) Beats Q2 CY2026 Sales Expectations - Yahoo Finance — Yahoo Finance Aug 5, 2026 positive
Latest item Oct 31, 2026 · Generated 2026-11-04T11:34:31Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductWeight Management55%10-K Item 1: 'Weight Management ... 54.5%'
- MEDIUMProductFormula 1 Healthy Meal25%10-K Item 1A: 'Our Formula 1 Healthy Meal, which is our best-selling product line, approximated 25% of our net sales for the year ended December 31, 2025.'
- HIGHCustomerindependent Members10-K Item 1A: 'We distribute our products exclusively to and through our independent Members, and we depend on them directly for substantially all of our sales.'
Material Events(8-K, last 90d)
- 2026-05-01Item 1.01MEDIUMOn April 29, 2026, HLF Financing SaRL and Herbalife International Inc. issued $800 million of 7.750% Senior Secured Notes due May 1, 2033 to qualified institutional buyers. Notes secured on senior basis; governed by indenture with Citibank N.A. as trustee and collateral agent.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $14.38, A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: Weight Management (54.5%); Concentration risk — Customer: independent Members. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $13.37. Score 6.4/10, moderate confidence.
Analyst target: $14.73 (+2.5% upside). Prior stop was $13.37. Stop-loss: $13.37.
Concentration risk — Product: Weight Management (54.5%); Concentration risk — Customer: independent Members; Analyst target reached - limited upside remaining.
Herbalife Ltd. trades at a P/E of 8.5 (forward 4.8). TrendMatrix value score: 8.7/10. Verdict: Sell.
9 analysts rate HLF, with a consensus score of 4.0/5. 3 analysts publish price targets averaging $17.
What does Herbalife Ltd. do?Herbalife sells nutrition and wellness products — weight management (54.5% of 2025 net sales), targeted nutrition,...
Herbalife sells nutrition and wellness products — weight management (54.5% of 2025 net sales), targeted nutrition, sports, and outer nutrition — through a direct-selling network of approximately 6.4 million Members across 95 markets. Revenue is earned when Members purchase at wholesale for resale; the Formula 1 Healthy Meal line alone approximated 25% of net sales. Three company-owned HIM manufacturing facilities produce approximately 46% of inner nutrition products sold worldwide.